The Aurum Institute is pleased to announce the enrolment of the first participant in its clinical trial testing two host-directed therapies (HDTs) in patients with drug-resistant tuberculosis (DRTB-HDT). The milestone was reached by the study team at the Isango Lethemba TB Research Unit in Port Elizabeth, South Africa, under the direction of Dr Francesca Conradie....

Recent Articles

Post Category